Total Payments
$7,929
2024 Payments
$2,488
Companies
27
Transactions
496
Medicare Patients
2,830
Medicare Billing
$170,852
Payment Breakdown by Category
Food & Beverage$7,503 (94.6%)
Education$425.93 (5.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,503 | 491 | 94.6% |
| Education | $425.93 | 5 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,420 | 101 | $0 (2024) |
| Janssen Biotech, Inc. | $989.59 | 79 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $861.10 | 48 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $569.50 | 46 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $551.41 | 35 | $0 (2024) |
| PFIZER INC. | $508.53 | 28 | $0 (2024) |
| Galderma Laboratories, L.P. | $420.16 | 22 | $0 (2024) |
| Lilly USA, LLC | $382.25 | 20 | $0 (2024) |
| GENZYME CORPORATION | $353.32 | 20 | $0 (2024) |
| LEO Pharma Inc. | $303.32 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,488 | 140 | Janssen Biotech, Inc. ($399.71) |
| 2023 | $1,881 | 124 | ABBVIE INC. ($477.65) |
| 2022 | $2,026 | 142 | ABBVIE INC. ($442.93) |
| 2021 | $1,535 | 90 | Galderma Laboratories, L.P. ($320.24) |
All Payment Transactions
496 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Inflammation & Immunology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.85 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.69 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Dermatology | ||||||
| 11/15/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $26.33 | General |
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.39 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $31.66 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Immunology | ||||||
| 10/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: DERMATOLOGY | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 650 | 1,011 | $89,166 | $35,860 |
| 2022 | 12 | 730 | 1,126 | $116,875 | $48,502 |
| 2021 | 12 | 778 | 1,340 | $120,662 | $51,458 |
| 2020 | 13 | 672 | 1,095 | $97,439 | $35,032 |
Total Patients
2,830
Total Services
4,572
Medicare Billing
$170,852
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 173 | 219 | $19,710 | $11,072 | 56.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 114 | 141 | $23,970 | $9,275 | 38.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 82 | 94 | $15,040 | $5,018 | 33.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 100 | 124 | $14,260 | $3,332 | 23.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 49 | 55 | $3,575 | $1,929 | 54.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $4,650 | $1,800 | 38.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 65 | 303 | $3,636 | $1,301 | 35.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 24 | 31 | $2,635 | $1,067 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 13 | $1,690 | $1,066 | 63.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 123 | 153 | $26,010 | $10,828 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 142 | 176 | $15,840 | $9,116 | 57.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 99 | 116 | $18,560 | $6,138 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 79 | $10,270 | $5,868 | 57.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 89 | 118 | $13,570 | $3,507 | 25.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 15 | 17 | $7,820 | $3,140 | 40.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 33 | 33 | $4,950 | $2,111 | 42.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 30 | 53 | $4,505 | $1,967 | 43.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 50 | 56 | $3,640 | $1,701 | 46.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 56 | 295 | $3,540 | $1,463 | 41.3% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 12 | 16 | $3,200 | $1,344 | 42.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 13 | 14 | $4,970 | $1,320 | 26.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 152 | 193 | $17,370 | $9,773 | 56.3% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 109 | 135 | $22,950 | $9,471 | 41.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 85 | 110 | $14,300 | $8,171 | 57.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 112 | 133 | $21,280 | $7,581 | 35.6% |
About Brooke Stidham, PAC
Brooke Stidham, PAC is a Physician Assistant healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2010. The National Provider Identifier (NPI) number assigned to this provider is 1134450497.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brooke Stidham, PAC has received a total of $7,929 in payments from pharmaceutical and medical device companies, with $2,488 received in 2024. These payments were reported across 496 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($7,503).
As a Medicare-enrolled provider, Stidham has provided services to 2,830 Medicare beneficiaries, totaling 4,572 services with total Medicare billing of $170,852. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Austin, TX
- Active Since 01/26/2010
- Last Updated 03/20/2017
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1134450497
Products in Payments
- TREMFYA (Drug) $804.94
- DUPIXENT (Biological) $700.85
- SKYRIZI (Biological) $682.26
- EUCRISA (Drug) $392.48
- RINVOQ (Biological) $382.83
- COSENTYX (Biological) $300.14
- Otezla (Drug) $269.99
- COSENTYX (Drug) $251.21
- TALTZ (Drug) $246.33
- Sotyktu (Drug) $227.50
- ILUMYA (Biological) $211.24
- Winlevi (Drug) $203.90
- ADBRY (Biological) $191.41
- BOTOX (Biological) $190.02
- REMICADE (Biological) $184.65
- ZILXI (Drug) $135.04
- OPZELURA (Drug) $130.59
- Cimzia (Drug) $121.91
- CIBINQO (Drug) $116.05
- ENSTILAR (Drug) $111.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Austin
Ms. Selina Santos, Pa-C, PA-C
Physician Assistant — Payments: $465,204
Physician Assistant $465,204
Mr. Stephen Ingram, Pa, PA
Physician Assistant — Payments: $151,100
Physician Assistant $151,100
Mrs. Ashlea Lucas, Pa-C, PA-C
Physician Assistant — Payments: $21,745
Physician Assistant $21,745
Rachel Miller, Pac, PAC
Physician Assistant — Payments: $15,264
Physician Assistant $15,264
Mrs. Alexis Holder, Pa, PA
Physician Assistant — Payments: $14,510
Physician Assistant $14,510
Samantha Eshelman
Physician Assistant — Payments: $14,505
Physician Assistant $14,505